Treatment of patients with locally advanced rectal cancer. TEGAFOX (UFT/leukovorin og Oxaliplatin) before, during and after curatively intended radiotherapy. A Danish phase I/II trial.

Trial Profile

Treatment of patients with locally advanced rectal cancer. TEGAFOX (UFT/leukovorin og Oxaliplatin) before, during and after curatively intended radiotherapy. A Danish phase I/II trial.

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 07 Nov 2012

At a glance

  • Drugs Oxaliplatin (Primary) ; Tegafur/uracil (Primary) ; Folinic acid
  • Indications Rectal cancer
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms TEGAFOX
  • Most Recent Events

    • 23 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top